EM Phase I Safety Report

I’ll give you a complete event description that occurred during a Phase I clinical trial whose core aim is to evaluate safety. Using that source text, I need a concise yet regulator-ready EM pharmaceutical investigation report.

Your task is to transform the narrative I provide into a structured document that:
• summarises the incident clearly,
• details the immediate and root-cause analyses,
• outlines corrective and preventive actions, and
• frames everything within current ICH-GCP and FDA safety-reporting expectations.

Please deliver the final investigation as a Word document with numbered sections and clean, professional language. A brief cover memo highlighting key safety findings and next-step recommendations should accompany the main report. I will review the draft once; after my comments are incorporated, the assignment is complete.